Laviceftra 1000mg Injection
Marketer
Lavish Biotech
Salt Composition
Ceftriaxone (1000mg)
Overview Laviceftra 1000mg Injection
Cefixime 1000mg injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications span diverse sites: brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it prevents surgical site infections. Administered intravenously or intramuscularly by a healthcare professional, dosage is individually determined. Consistent, evenly spaced doses, as prescribed, are crucial; premature cessation risks relapse or intensified infection. Common adverse effects comprise diarrhea, rash, altered liver function test results, and atypical blood cell counts (e.g., elevated eosinophils, leukopenia, thrombocytopenia). Transient injection site redness or pain may occur. While usually mild, persistent or bothersome effects warrant medical attention. Prior to use, disclose antibiotic allergies, hepatic or renal impairment, and all concurrent medications to your doctor, as interactions are possible.
Primary Ingredients of Laviceftra 1000mg Injection
No text was provided to rewrite.
Uses of Laviceftra 1000mg Injection
Combating Bacterial Infections
Major Benefits of Laviceftra 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Laviceftra 1000mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Laviceftra 1000mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Laviceftra 1000mg Injection works:
The antibiotic injection, Laviceftra 1000mg, works by disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's essential protective barrier and leading to their demise.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Laviceftra 1000mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable form of Laviceftra, at a 1000mg dose, presents minimal to no documented risk to the fetus during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Laviceftra 1000mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Laviceftra 1000mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Laviceftra 1000mg Injection is considered safe and does not require dosage modification. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advised.
LiverCAUTION
For individuals with severe hepatic impairment, administration of Laviceftra 1000mg Injection requires careful consideration and potential dosage modification. Patients with mild to moderate liver disease, however, do not typically require dosage alteration of Laviceftra 1000mg Injection. Physician consultation is advised.
What if you forget to take Laviceftra 1000mg Injection :
Omitting a scheduled dose of Laviceftra 1000mg Injection requires contacting your physician.
Facts to Know About Laviceftra 1000mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently